Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...

Discover how rheumatoid arthritis advances through distinct stages, the symptoms at each phase, and treatment approaches that ...

Rheumatoid arthritis (RA) treatment usually includes ... Talk with a doctor about all your treatment plan possibilities, including biologics. Weigh the pros and cons of each treatment and drug ...

Fan Zhang, Ph.D., sees artificial intelligence as a pathway to finding an effective way to combat an intractable enemy: ...

Among US veterans with rheumatoid arthritis, the use of biologic/targeted synthetic DMARDs does not appear to increase the risk of developing multiple myeloma. The use of biologic and targeted ...

However, despite subsequent approvals for JIA, many patients with other types of childhood arthritis remain without options. Since May of 1999, the FDA has approved several biologic disease ...

Rheumatoid arthritis (RA) is a chronic ... In recent times, the newer group of biologics has increased treatment options. Science X Daily and the Weekly Email Newsletter are free features that ...

Original Medicare covers most medically necessary rheumatoid arthritis (RA) treatments, including biologics. Medicare Part D or Part B covers eligible prescription drug expenses. Which one covers ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

If this medication doesn't work for you, your healthcare provider may switch to a biologic medication or add additional ...

Rheumatoid arthritis (RA) is a chronic ... In the past decade, the emergence of biologic DMARDs, which are used as a monotherapy and in combination with MTX, has had a major impact on patient ...